HOME >> BIOLOGY >> NEWS
Biotech Creates New Solutions And New Problems

Since recombinant DNA techniques were first developed by University of California, San Francisco, and Stanford University scientists in 1973, biotechnology has found commercial application in medicine, food processing and, more recently, agriculture. This year U.S. growers planted 45 million acres of transgenic crops, including herbicide-tolerant, insect- and disease-resistant varieties. But while transgenic crops offer new options for California farmers, they raise questions as well. This issue of California Agriculture explores two of them: how privatization of proprietary rights to key biotechnology will affect public germplasm development, and how the problems of pest resistance may affect the long-term success of larvae-killing transgenic cotton.

Genetic materials ranging from DNA sequences to whole plants, as well as essential biotechnology tools and techniques, are being patented by private and public research entities. At the same time, a series of mergers and acquisitions in the agrochemical and seed industries has led to increasing dominance by a small number of corporations in these fields. Such industrywide changes signal a profound shift in the ownership of life forms and the recombinant DNA tools needed to manipulate them. These changes present problems both for growers of major crops, who find they have an increasingly limited number of suppliers, and growers of minor crops, who may find that transgenic research useful to them is never developed because the potential market is too small.

Plants genetically engineered to produce insecticidal proteins of the bacterium Bacillus thuringiensis provide effective, environmentally safe pest control. However, current transgenic crops have in some cases encountered insect resistance, partly because they have been engineered to produce only a single type of Bt insecticidal protein, and partly because as crop plants age they may produce lower amounts of the Bt protein.


'"/>

Contact: Pam Kan-Rice
pamela.kan-rice@ucop.edu
510-987-0043
University of California - Division of Agriculture & Natural Resources
22-Dec-1998


Page: 1 2 3

Related biology news :

1. Nanosphere announces genetic detection advance in Nature Biotechnology
2. Leroy Hood to receive 2004 Biotechnology Heritage Award
3. Christopher Walsh wins 2004 Promega Biotechnology Research Award
4. Advancing Biotechnology Breakthroughs
5. Bacteriophage genomics approach to antimicrobial drug discovery published in Nature Biotechnology
6. Quark Biotech generates a cholesterol-free mouse
7. Army awards up to $50 million to establish Institute for Collaborative Biotechnologies
8. US-EC Biotech Task Force keys on research, collaboration
9. Chemical Heritage Foundation and BIO give Biotechnology Heritage Award to William Rutter
10. Biotechnology taught as a tool for teaching
11. Biotech regulations impede crop domestication

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biotech Creates New Solutions And New Problems

(Date:12/3/2014)... , Dec. 2, 2014   Marvin ... deployed, innovative test solutions for military, aerospace, and ... version of its successful TS-900 PXI semiconductor ... and features of high-end systems to customers at ... value compared to traditional ATE. ...
(Date:11/21/2014)... Strict laws against distracted driving and the ... American and European automotive sector towards gesture recognition technologies. ... that are intuitive and able to retrieve information with ... New analysis from Frost & Sullivan,s Strategic ... Europe and North America ...
(Date:11/18/2014)... , Nov. 17, 2014   ... and EMC collaborate to develop The Partners Data ... , The Partners Data Lake will allow researcher ... improve diagnostics, treatment and the lives of patients ... research and clinical activities across the Partners system, ...
Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
(Date:12/19/2014)... 18, 2014 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... of chronic pain, announced the results of its annual ... was a transformational year in Relmada,s history and it ... company," said Sergio Traversa , chief executive officer ... on key financial, human resource and clinical development objectives ...
(Date:12/17/2014)... N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today announced ... (referred to as Somatuline®) was approved by the ... treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult ... advanced or metastatic disease to improve progression-free survival ...
(Date:12/17/2014)... 17, 2014 Audacity, a leading California-based ... member of the Huntsworth Health Group, is proud to ... team. In her role, Gonzales will serve as Senior ... incredibly honored to welcome a talent of Jamie’s caliber ... Gaëtan Fraikin. “She is a proven healthcare innovation leader ...
(Date:12/17/2014)... Mass. , Dec. 17, 2014   Synageva ... biopharmaceutical company developing therapeutic products for rare disorders, announced ... Conference being held in San Francisco, CA. ... President and Chief Executive Officer, will present on Monday, ... EST).  The presentation will be webcast live and may ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
Cached News: